Research progress of NLRP3 inflammasome in the treatment of uveitis
10.3980/j.issn.1672-5123.2024.4.14
- VernacularTitle:NLRP3炎症小体在葡萄膜炎中的研究进展
- Author:
Min ZHOU
1
,
2
;
Qiuming HU
1
,
2
Author Information
1. Guangxi University of Chinese Medicine, Nanning 530200, Guangxi Zhuang Autonomous Region, China
2. Department of Ophthalmology, Taoyuan Hospital of Traditional Chinese Medicine, Taoyuan 415700, Hunan Province, China
- Publication Type:Journal Article
- Keywords:
NLRP3 inflammasome;
activation pathways;
uveitis;
Behcet's disease;
Vogt-Koyanagi Harada Syndrome
- From:
International Eye Science
2024;24(4):572-576
- CountryChina
- Language:Chinese
-
Abstract:
The NLRP3 inflammasome is a cellular multimeric protein complex that plays a crucial role in inflammation and immune responses. It consists of three main components: Nod-like receptor protein 3(NLRP3), apoptosis-associated speck-like protein containing(ASC)and cysteine protease 1(caspase-1). Uveitis is a broad term encompassing a range of inflammatory diseases that primarily affect the iris, ciliary body, vitreous, retina and choroid. It is considered a major cause of blindness globally. Numerous studies have demonstrated the involvement of NLRP3 inflammasome in the onset and progression of uveitis, indicating its potential as a significant therapeutic target for uveitis in the future. This article provides an overview of the structure, biological functions and activation pathways of the NLRP3 inflammasome, as well as the current research progress on its association with different types of uveitis. Additionally, it discusses the application potential of the NLRP3 inflammasome in the treatment of uveitis.
